Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,439.55 +58.20 (+0.69%) Bitcoin USD
63,025.04 +2,094.30 (+3.44%) CMC Crypto 200
1,302.28 -55.73 (-4.11%)
Blackbaud, Inc. (BLKB)
After hours:
| Previous close | 77.26 |
| Open | 77.40 |
| Bid | 77.62 x 100 |
| Ask | 77.97 x 100 |
| Day's range | 76.79 - 77.91 |
| 52-week range | 64.32 - 88.56 |
| Volume | |
| Avg. volume | 319,570 |
| Market cap | 4.009B |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | 189.41 |
| EPS (TTM) | 0.41 |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 27 Feb 2020 |
| 1y target est | 83.12 |
PR NewswireBlackbaud Makes a Strategic Investment in UBIQ Education
Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, today announced a strategic investment in UBIQ Education, innovators in school websites through the introduction of AMAIS, the first digital experience ecosystem (DXE) for schools.
FortuneCSR is a core business function. It’s time to treat it that way
Increasingly, companies are strategizing how to use CSR to rebuild trust and transparency.
PR NewswireEVERFI from Blackbaud's Prescription Drug Safety Course Certified as Meeting Rigorous ESSA Evidence Standards
EVERFI® from Blackbaud®, the leader in powering social impact through education, today announced that its program, Prescription Drug Safety: Know the truth, has been certified as meeting the evidence-based standards outlined in the Every Student Succeeds Act (ESSA), aligning with Level III certification for "Promising Evidence." This certification demonstrates that usage of the course correlates with students' personal responsibility, perceived social norms, knowledge of safe prescription drug u
